What's new

Human medicines European public assessment report (EPAR): Vyloy, Zolbetuximab, Date of authorisation: 19/09/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Vyloy, Zolbetuximab, Date of authorisation: 19/09/2024, Revision: 2, Status: Authorised

Apr 9, 2025 - 13:27
 0
Human medicines European public assessment report (EPAR): Vyloy, Zolbetuximab, Date of authorisation: 19/09/2024, Revision: 2, Status: Authorised
Human medicines European public assessment report (EPAR): Vyloy, Zolbetuximab, Date of authorisation: 19/09/2024, Revision: 2, Status: Authorised
Read More

Tags:

Previous Article

Emergency?

Next Article

Human medicines European public assessment report (EPAR): Besremi, ropeginterfer...

Related Posts

European Surveillance of Veterinary Antimicrobial Consumption (ESVAC): 2009 - 2023

European Surveillance of Veterinary Antimicrobial Consu...

Mar 31, 2025  0

Human medicines European public assessment report (EPAR): Zebinix, eslicarbazepine acetate, Date of authorisation: 21/04/2009, Revision: 32, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 31, 2025  0

Human medicines European public assessment report (EPAR): Clopidogrel Viatris (previously Clopidogrel Taw Pharma), clopidogrel, Date of authorisation: 16/10/2009, Revision: 28, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 15, 2025  0